“…The clinical samples were strongly positive for PCV3, with Cq values between 14.9 and 39.08, and 35 tissue samples and 18 serum samples among the 170 clinical samples were found to be positive for PCV3. The overall positive detection rate was 31.18% (53/170, 95% CI: 23.92–38.43) (Table ), which was basically consistent with some previous reports (Stadejek et al., ; Kim et al., ; Ku et al., ), but lower than those reported by others (Zheng et al., ; Kwon et al., ). For 2013, 2014, 2015, 2016 and 2017, the PCV3‐positive detection rates were 23.08% (3/13, 95% CI: 3.67–49.83), 20% (1/5, 95% CI: 25.06–65.06), 42.86% (3/7, 95% CI: 0.95–86.66), 38.78% (19/49, 95% CI: 24.11–53.44) and 28.13% (27/96, 95% CI: 18.61–37.64), respectively.…”